Myeloma Crowd: Now Enrolling for PCROWD study: Patients with precursor conditions such as MGUS & Smo

Most blood cancers are preceded by clonal disease states that then progress into disease. However, the genomic, genetic, and epigenetic factors governing the process of progression and therapeutic resistance have not been systematically characterized. +read more

Recent Posts

See All

Honoring a decade of Standing Up To Cancer

On September 7, Stand Up To Cancer’s (SU2C) telecast shared inspiring stories of hope, perseverance, and groundbreaking cancer research to a worldwide audience. +read more

DFCI Logo Lens Stacked PNG_edited.png
CPOP_R02.png

© 2018 Dana-Farber Cancer Institute |  Terms of Use  |   Privacy Policy